Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FS5GD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,856
Award facts
- Contract value 100% obligated
- $26,856.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) with a ceiling value of $26,856.13. This non-set-aside contract was awarded on a firm fixed-price basis with an ultimate completion date of June 5, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999.9 million through December 2026 and serves as a comprehensive pharmaceutical supply vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor, supplies a broad range of medications and medical commodities to federal customers including the Defense Health Agency and U.S. Coast Guard. RINVOQ ER (upadacitinib extended-release) is a JAK inhibitor used in the treatment of rheumatoid arthritis and other inflammatory conditions. The company's extensive portfolio of federal contract awards demonstrates its established capability to meet competitive procurement requirements for specialized pharmaceutical products across multiple therapeutic domains, making it a critical vendor for the Department of Defense's medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FS5GD?
SPE2DB25FS5GD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 4, 2025.
How much is contract SPE2DB25FS5GD worth?
The government has obligated $26,856 on SPE2DB25FS5GD.
Is contract SPE2DB25FS5GD an order under another contract?
Yes. SPE2DB25FS5GD is a delivery order under SPE2DB22D2214, an indefinite delivery contract.
Was contract SPE2DB25FS5GD competed?
The extent of competition for SPE2DB25FS5GD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award